Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.
Sep 22, 2014
0
9
For the first time, researchers have successfully used bacteriophages—viruses that kill bacteria—to treat an antibiotic-resistant mycobacterial lung infection, clearing the way for a young National Jewish Health patient ...
May 13, 2022
0
406
Developing new medicines to treat pulmonary fibrosis, one of the most common and serious forms of lung disease, is not easy.
May 25, 2018
1
109
Scientists at Vanderbilt University Medical Center (VUMC) and the Translational Genomics Research Institute (TGen) in Phoenix, Arizona, have discovered previously unreported genetic and cellular changes that occur in the ...
Jul 8, 2020
0
94
Using a new recipe for growing blood vessels from living lung tissue in the lab, a University of Virginia School of Engineering and Applied Science research team has developed an analytical tool that could lead to a cure ...
Sep 30, 2023
1
102
A team of scientists from the UNC School of Medicine and North Carolina State University (NCSU) has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary ...
Aug 3, 2017
0
531
While most people recover from COVID-19 within a week or two, up to one-third of survivors experience persistent or new symptoms weeks and months after initial infection.
Jul 20, 2022
0
102
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic ...
Oct 21, 2011
0
0
A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.
Nov 15, 2019
0
75
Researchers have identified a promising new treatment for non-cystic fibrosis bronchiectasis, a long-term lung disorder which causes persistent coughing and breathlessness. The results, published in the Lancet, could represent ...
Aug 16, 2012
0
0
